Skip to content
  • Saturday, 22 August 2026
  • 6:14 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Pioneering Mass Spectrometry Innovator Albert Heck Honored with John B. Fenn Distinguished Contribution Award at ASMS 2026
Biotech & Genetic Research

Pioneering Mass Spectrometry Innovator Albert Heck Honored with John B. Fenn Distinguished Contribution Award at ASMS 2026

Jia Lissa Jul 4, 2026 0

Albert Heck, Professor of Biomolecular Mass Spectrometry (MS) and Proteomics at Utrecht University in The Netherlands, a visionary whose groundbreaking…

Read More
Unconscious Brain Activity During General Anesthesia Reveals Sophisticated Language Processing and Predictive Capabilities in the HippocampusScientific Breakthrough Reveals Human Heart Muscle Regeneration in Artificial Heart Patients Offering New Hope for Heart Failure CureThe Universe as a Cosmic Ledger: New Quantum Memory Matrix Theory Challenges Foundations of Physics and CosmologyUnveiling the Explosive Origins of Chronic Myeloid Leukemia: New Genomic Research Reveals Rapid Pre-Diagnostic Growth and Treatment Implications
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ